Gaby Palmer

8.8k total citations · 2 hit papers
107 papers, 7.2k citations indexed

About

Gaby Palmer is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Gaby Palmer has authored 107 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Immunology, 39 papers in Molecular Biology and 18 papers in Rheumatology. Recurrent topics in Gaby Palmer's work include IL-33, ST2, and ILC Pathways (29 papers), Inflammasome and immune disorders (19 papers) and Immune Response and Inflammation (19 papers). Gaby Palmer is often cited by papers focused on IL-33, ST2, and ILC Pathways (29 papers), Inflammasome and immune disorders (19 papers) and Immune Response and Inflammation (19 papers). Gaby Palmer collaborates with scholars based in Switzerland, United States and France. Gaby Palmer's co-authors include Cem Gabay, Céline Lamacchia, Dominique Talabot‐Ayer, Joseph Caverzasio, William P. Arend, Praxedis Martin, Atsushi Suzuki, Jérôme Guicheux, Jean‐Philippe Bonjour and Emiliana Rodriguez and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Immunity.

In The Last Decade

Gaby Palmer

105 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL‐1, IL‐18, and IL‐33 families of cytokines

2008 706 citations Gaby Palmer, Cem Gabay et al. profile →
IL-1 pathways in inflammation and human diseases

2010 700 citations Cem Gabay, Céline Lamacchia et al. profile →

Peers

Countries citing papers authored by Gaby Palmer

Since Specialization

Citations

This map shows the geographic impact of Gaby Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaby Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaby Palmer more than expected).

Fields of papers citing papers by Gaby Palmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaby Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaby Palmer. The network helps show where Gaby Palmer may publish in the future.

Co-authorship network of co-authors of Gaby Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Gaby Palmer. A scholar is included among the top collaborators of Gaby Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaby Palmer. Gaby Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Full-length and N-terminally truncated recombinant interleukin-38 variants are similarly inefficient in antagonizing interleukin-36 and interleukin-1 receptors 2025 ·Cell Communication and Signaling ·(unknown), Dominique Talabot‐Ayer, (unknown), Gea Cereghetti, (unknown), Mike Maillasson, Antonio Francés‐Monerris, Erwan Mortier, Gaby Palmer	0
2	GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model 2024 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Sébastien Fauteux‐Daniel, Pratyaksha Wirapati, (unknown), Jean‐Christophe Tille, Thomas McKee, Mikäel J. Pittet, Gaby Palmer, Carole Bourquin	1
3	Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in mice 2024 ·Frontiers in Immunology ·(unknown), Emiliana Rodriguez, Dominique Talabot‐Ayer, Andreas Weigert, Gaby Palmer	2
4	IL‐38 orchestrates proliferation and differentiation in human keratinocytes 2022 ·Experimental Dermatology ·(unknown), Maria S. Shutova, (unknown), Dominique Talabot‐Ayer, Justyna Drukała, (unknown), Gürkan Kaya, Wolf‐Henning Boehncke, Gaby Palmer, Julia Borowczyk	16
5	Inhibition of IL-1β release from macrophages targeted with necrosulfonamide-loaded porous nanoparticles 2022 ·Journal of Controlled Release ·(unknown), Karin Möller, (unknown), (unknown), (unknown), Sébastien Fauteux‐Daniel, Carole Bourquin, Gaby Palmer, Thomas Bein	14
6	IL-38 Ablation Reduces Local Inflammation and Disease Severity in Experimental Autoimmune Encephalomyelitis 2021 ·The Journal of Immunology ·(unknown), (unknown), Ann-Christin Frank, (unknown), Dominik C. Fuhrmann, M. Hofmann, (unknown), Gaby Palmer, Bernhard Brüne, Natasja de Bruin, Andreas Weigert	16
7	IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro 2017 ·Annals of the Rheumatic Diseases ·Marie‐Astrid Boutet, Aurélie Najm, Géraldine Bart, Régis Brion, S. Touchais, Valérie Trichet, Pierre Layrolle, Cem Gabay, Gaby Palmer, Frédéric Blanchard, Benoît Le Goff	105
8	IL-36–Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid Cells 2016 ·The Journal of Immunology ·Jennifer Palomo, Béatris Mastelic-Gavillet, Estelle Woldt, (unknown), Emiliana Rodriguez, Gaby Palmer, Claire‐Anne Siegrist, Cem Gabay	6
9	The interleukin (IL)-1 cytokine family – Balance between agonists and antagonists in inflammatory diseases 2015 ·Cytokine ·Jennifer Palomo, Damien Dietrich, Praxedis Martin, Gaby Palmer, Cem Gabay	352
10	Limited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection 2015 ·PLoS ONE ·(unknown), Solenne Vigne, Gaby Palmer, Marie-Laure Bourigault, Maria L. Olleros, Dominique Vesin, Irène Garcia, Bernhard Ryffel, Valérie Quesniaux, Cem Gabay	34
11	Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice 2011 ·Annals of the Rheumatic Diseases ·Céline Lamacchia, Emiliana Rodriguez, Gaby Palmer, Solenne Vigne, Praxedis Martin, Dominique Talabot‐Ayer, Christian A. Seemayer, Cem Gabay	13
12	Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell–specific interleukin‐1 receptor antagonist 2010 ·Arthritis & Rheumatism ·Céline Lamacchia, Gaby Palmer, Christian A. Seemayer, Dominique Talabot‐Ayer, Cem Gabay	45
13	Adaptive Immune Response in JAM-C-Deficient Mice: Normal Initiation but Reduced IgG Memory 2009 ·The Journal of Immunology ·(unknown), Boris P.-L. Lee, Gaby Palmer, Cem Gabay, Ralf H. Adams, Michel Aurrand‐Lions, Beat A. Imhof	13
14	Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage 2009 ·Journal of Biological Chemistry ·Dominique Talabot‐Ayer, Céline Lamacchia, Cem Gabay, Gaby Palmer	207
15	Indirect Effects of Leptin Receptor Deficiency on Lymphocyte Populations and Immune Response in db/db Mice 2006 ·The Journal of Immunology ·Gaby Palmer, Michel Aurrand‐Lions, Emmanuel Contassot, Dominique Talabot‐Ayer, (unknown), Christian Vesin, Véronique Chobaz-Péclat, Nathalie Busso, Cem Gabay	68
16	Is IL-1 a good therapeutic target in the treatment of arthritis? 2006 ·Best Practice & Research Clinical Rheumatology ·Danielle Burger, Jean‐Michel Dayer, Gaby Palmer, Cem Gabay	132
17	The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes 2006 ·Arthritis Research & Therapy ·David Magne, Gaby Palmer, Jenny L. Barton, Françoise Mézin, Dominique Talabot‐Ayer, Sylvette Bas, (unknown), (unknown), Pierre‐André Guerne, Martin J.H. Nicklin, Cem Gabay	112
18	The active metabolite of leflunomide, A77 1726, increases proliferation of human synovial fibroblasts in presence of IL-1β and TNF-α 2006 ·Inflammation Research ·David Magne, Françoise Mézin, Gaby Palmer, P A Guerne	8
19	Mice transgenic for intracellular interleukin‐1 receptor antagonist type 1 are protected from collagen‐induced arthritis 2003 ·European Journal of Immunology ·Gaby Palmer, Dominique Talabot‐Ayer, (unknown), (unknown), William P. Arend, Cem Gabay	30
20	Regulation of Alkaline Phosphatase Activity by p38 MAP Kinase in Response to Activation of Gi Protein-Coupled Receptors by Epinephrine in Osteoblast-Like Cells¹ 1999 ·Endocrinology ·Atsushi Suzuki, Gaby Palmer, Jean‐Philippe Bonjour, Joseph Caverzasio	95

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact